These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 19343734)

  • 21. Prospective analysis of prostate-specific markers in pelvic lymph nodes of patients with high-risk prostate cancer.
    Ferrari AC; Stone NN; Eyler JN; Gao M; Mandeli J; Unger P; Gallagher RE; Stock R
    J Natl Cancer Inst; 1997 Oct; 89(20):1498-504. PubMed ID: 9337346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative detection of micrometastases in pelvic lymph nodes in patients with clinically localized prostate cancer by real-time reverse transcriptase-PCR.
    Miyake H; Hara I; Kurahashi T; Inoue TA; Eto H; Fujisawa M
    Clin Cancer Res; 2007 Feb; 13(4):1192-7. PubMed ID: 17317829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate Cancer.
    Schmidkonz C; Cordes M; Beck M; Goetz TI; Schmidt D; Prante O; Bäuerle T; Uder M; Wullich B; Goebell P; Kuwert T; Ritt P
    Clin Nucl Med; 2018 Apr; 43(4):225-231. PubMed ID: 29401151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging.
    Kabasakal L; Demirci E; Ocak M; Akyel R; Nematyazar J; Aygun A; Halac M; Talat Z; Araman A
    Nucl Med Commun; 2015 Jun; 36(6):582-7. PubMed ID: 25738559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete androgen ablation suppresses prostate stem cell antigen (PSCA) mRNA expression in human prostate carcinoma.
    Zhigang Z; Wenlu S
    Prostate; 2005 Dec; 65(4):299-305. PubMed ID: 16015594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of different prostatic markers in lymph node and distant metastases of prostate cancer.
    Queisser A; Hagedorn SA; Braun M; Vogel W; Duensing S; Perner S
    Mod Pathol; 2015 Jan; 28(1):138-45. PubMed ID: 24925052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. External beam radiotherapy (EBRT) suppressed prostate stem cell antigen (PSCA) mRNA expression in clinically localized prostate cancer.
    Zhigang Z; Wenlu S
    Prostate; 2007 May; 67(6):653-60. PubMed ID: 17342746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate stem cell antigen expression is associated with gleason score, seminal vesicle invasion and capsular invasion in prostate cancer.
    Han KR; Seligson DB; Liu X; Horvath S; Shintaku PI; Thomas GV; Said JW; Reiter RE
    J Urol; 2004 Mar; 171(3):1117-21. PubMed ID: 14767283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HOXB13 protein expression in metastatic lesions is a promising marker for prostate origin.
    Varinot J; Furudoï A; Drouin S; Phe V; Penna RR; Roupret M; Bitker MO; Cussenot O; Compérat E
    Virchows Arch; 2016 May; 468(5):619-22. PubMed ID: 26931741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of androgen deprivation therapy on PSMA expression and PSMA-ligand PET imaging of prostate cancer patients.
    Vaz S; Hadaschik B; Gabriel M; Herrmann K; Eiber M; Costa D
    Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):9-15. PubMed ID: 31654093
    [No Abstract]   [Full Text] [Related]  

  • 31. Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer.
    Dannull J; Diener PA; Prikler L; Fürstenberger G; Cerny T; Schmid U; Ackermann DK; Groettrup M
    Cancer Res; 2000 Oct; 60(19):5522-8. PubMed ID: 11034097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer.
    Reiter RE; Gu Z; Watabe T; Thomas G; Szigeti K; Davis E; Wahl M; Nisitani S; Yamashiro J; Le Beau MM; Loda M; Witte ON
    Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1735-40. PubMed ID: 9465086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PSMA expression in Schwannoma: a potential clinical mimicker of metastatic prostate carcinoma.
    Wang W; Tavora F; Sharma R; Eisenberger M; Netto GJ
    Urol Oncol; 2009; 27(5):525-8. PubMed ID: 18534872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate-specific membrane antigen expression in melanoma metastases.
    Snow H; Hazell S; Francis N; Mohammed K; O'Neill S; Davies E; Mansfield D; Messiou C; Hujairi N; Nicol D; Harrington K; Smith M
    J Cutan Pathol; 2020 Dec; 47(12):1115-1122. PubMed ID: 32529651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The loss of 5alpha-reductase type I and type II mRNA expression in metastatic prostate cancer to bone and lymph node metastasis.
    Habib FK; Ross M; Bayne CW; Bollina P; Grigor K; Chapman K
    Clin Cancer Res; 2003 May; 9(5):1815-9. PubMed ID: 12738739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of gastrin-releasing peptide receptor in epidermoid carcinoma of the anal canal.
    Martins FF; Contu PC; Meurer L; Schwartsmann G; Damin DC
    Appl Immunohistochem Mol Morphol; 2014 Jul; 22(6):459-63. PubMed ID: 23958544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers.
    Haffner MC; Kronberger IE; Ross JS; Sheehan CE; Zitt M; Mühlmann G; Ofner D; Zelger B; Ensinger C; Yang XJ; Geley S; Margreiter R; Bander NH
    Hum Pathol; 2009 Dec; 40(12):1754-61. PubMed ID: 19716160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients.
    Kurek R; Nunez G; Tselis N; Konrad L; Martin T; Roeddiger S; Aumüller G; Zamboglou N; Lin DW; Tunn UW; Renneberg H
    Clin Cancer Res; 2004 Sep; 10(17):5808-14. PubMed ID: 15355910
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Herlemann A; Wenter V; Kretschmer A; Thierfelder KM; Bartenstein P; Faber C; Gildehaus FJ; Stief CG; Gratzke C; Fendler WP
    Eur Urol; 2016 Oct; 70(4):553-557. PubMed ID: 26810345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative pathways to prostate carcinoma activate prostate stem cell antigen expression.
    Dubey P; Wu H; Reiter RE; Witte ON
    Cancer Res; 2001 Apr; 61(8):3256-61. PubMed ID: 11309275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.